These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 289426)

  • 41. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
    Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of erythroid differentiation and terminal cell division in induced Friend leukemia cells.
    Gambari R; Marks PA; Rifkind RA; Farace M; Fantoni A
    Acta Biol Med Ger; 1981; 40(4-5):511-8. PubMed ID: 7315096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells.
    Mallia CM; Aguirre V; McGary E; Tang Y; Scandurro AB; Liu C; Noguchi CT; Beckman BS
    Exp Cell Res; 1999 Feb; 246(2):348-54. PubMed ID: 9925750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid induction of human alpha, beta and gamma globin genes in transiently transfected mouse erythroleukemia cells.
    Jones RW; Campbell PL; Kulozik AE; Woodham JP
    Prog Clin Biol Res; 1989; 316B():197-208. PubMed ID: 2616575
    [No Abstract]   [Full Text] [Related]  

  • 45. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
    Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythroid cell differentiation: murine erythroleukemia cell variant with unique pattern of induction by polar compounds.
    Ohta Y; Tanaka M; Terada M; Miller OJ; Bank A; Marks P; Rifkind RA
    Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1232-6. PubMed ID: 177980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3' untranslated region.
    Russell JE; Liebhaber SA
    Blood; 1996 Jun; 87(12):5314-23. PubMed ID: 8652847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E; Reuben RC; Rifkind RA; Marks PA
    Cancer Res; 1977 Feb; 37(2):440-4. PubMed ID: 264411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition by dexamethasone of commitment to erythroid differentiation in murine erythroleukemia cells.
    Tsiftsoglou AS; Gusella JF; Volloch V; Housman DE
    Cancer Res; 1979 Oct; 39(10):3849-55. PubMed ID: 289436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of expression of a mouse alpha-globin gene by plasmids that include antisense oligonucleotides.
    Yokoyama K; Hou DX; Gao H; Tang X; Kitabayashi I; Nishikura K; Gachelin G
    Cell Struct Funct; 1992 Dec; 17(6):433-42. PubMed ID: 1295698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
    Kirsch IR; Bertness V; Silver J; Hollis GF
    J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CP2 binding to the promoter is essential for the enhanced transcription of globin genes in erythroid cells.
    Chae JH; Kim CG
    Mol Cells; 2003 Feb; 15(1):40-7. PubMed ID: 12661759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and conditions for selective expression of megakaryocytic markers in Friend erythroleukemia cells.
    Paoletti F; Vannucchi AM; Mocali A; Caporale R; Burstein SA
    Blood; 1995 Oct; 86(7):2624-31. PubMed ID: 7670106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extinction of globin gene expression in human fibroblast x mouse erythroleukemia cell hybrids.
    Deisseroth A; Velez R; Burk RD; Minna J; Anderson WF; Nienhuis A
    Somatic Cell Genet; 1976 Jul; 2(4):373-84. PubMed ID: 1071909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of transformed cells to terminal differentiation.
    Marks PA; Sheffery M; Ramsay R; Ikeda K; Rifkind RA
    Ann N Y Acad Sci; 1987; 511():246-55. PubMed ID: 3326466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A change in the stability of globin mRNA during the induction of murine erythroleukemia cells.
    Lowenhaupt K; Lingrel JB
    Cell; 1978 Jun; 14(2):337-44. PubMed ID: 667945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human globin gene expression after gene transfer.
    Bank A; Donovan-Peluso M; Lerner N; Rund D
    Blood Cells; 1987; 13(1-2):269-75. PubMed ID: 3478110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between ornithine decarboxylase activity and hexamethylene bisacetamide-induced differentiation of murine erythroleukemia cells.
    Meilhoc E; Moutin MJ; Romani BH; Osborne HB
    Exp Cell Res; 1986 Jan; 162(1):142-50. PubMed ID: 3079592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The LCR-like alpha-globin positive regulatory element functions as an enhancer in transiently transfected cells during erythroid differentiation.
    Pondel MD; George M; Proudfoot NJ
    Nucleic Acids Res; 1992 Jan; 20(2):237-43. PubMed ID: 1741249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.